Free Trial

International Biotechnology (LON:IBT) Share Price Crosses Above 200 Day Moving Average - Here's Why

International Biotechnology logo with Financial Services background

Key Points

  • International Biotechnology shares crossed above their 200-day moving average, indicating a potential bullish trend.
  • The stock last traded at GBX 708 ($9.61) after reaching a high of GBX 715.93 ($9.72) during the session.
  • The company aims for long-term capital growth by investing in biotechnology and life sciences firms with promising growth prospects.
  • MarketBeat previews top five stocks to own in November.

International Biotechnology (LON:IBT - Get Free Report) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 616.57 ($8.36) and traded as high as GBX 715.93 ($9.71). International Biotechnology shares last traded at GBX 708 ($9.60), with a volume of 87,239 shares.

International Biotechnology Price Performance

The company's 50-day moving average price is GBX 658.37 and its two-hundred day moving average price is GBX 616.54. The company has a market capitalization of £232.54 million, a price-to-earnings ratio of 1,427.39 and a beta of 0.21.

International Biotechnology Company Profile

(Get Free Report)

The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

Read More

Should You Invest $1,000 in International Biotechnology Right Now?

Before you consider International Biotechnology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.

While International Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.